Theraphi
The original 'plasma rejuvenation' device from the Dan Winter ecosystem — now positioned by the maker as superseded by PhiRay — explicitly traced to Antoine Priore's real French plasma research.
- The maker describes Theraphi as a broad-spectrum 'phase conjugate' plasma and ELF field device for cellular regeneration, based on the historical Priore plasma-tube approach.
- Its lineage is traced explicitly to Antoine Priore's plasma device — a real French research program reportedly studied by government scientists for cancer effects in the 1960s–70s.
- The maker cites Elizabeth Rauscher's FDA study on magnetic harmonics for pain as a correlate, and now states Theraphi is superseded by the more powerful, cheaper PhiRay.
A real, historically documented French researcher whose plasma device was studied (and controversially defunded) in mid-20th-century France — the Priore history is independently verifiable, distinct from Theraphi's own claims.
Cited across the Dan Winter product line; the Atlas has not yet independently located the specific study.
The maker's proprietary theory — not independently peer-reviewed.
EVERY NAME LINKS TO ITS PAGE ON THE MAP — SEE WHO ELSE CITES IT. NAMING A SOURCE IS NOT ENDORSING IT.
- How accurately does Theraphi's framing represent the actual Priore history, versus adopting it as branding? (The real Priore story is well-documented and worth reading independently.)
- Where is the Elizabeth Rauscher FDA study, by citation?
- Now that the maker calls Theraphi obsolete, what is the actual recourse or upgrade path for existing owners?
Theraphi is charted as the 'legacy/previous generation' entry in the Dan Winter plasma line — its successor, PhiRay, is charted separately and explicitly positions Theraphi as superseded (a rare case of a maker retiring its own flagship on the record).
Its most interesting feature is the Priore lineage: unlike most fringe-device origin stories, Antoine Priore's plasma research genuinely happened and is documented — the open question is how faithfully that history maps onto this modern product.
How does the real Priore history compare to Theraphi's framing of it?
The Priore program is independently documented; the Atlas is tracking a rigorous comparison of the history versus the marketing.
Report from the field →PhiRay
A $6,900 plasma-and-magnetic-field device marketed as the direct replacement for the maker's earlier Theraphi system — claimed to be 2–4x more powerful at roughly a quarter of the cost.
Plasmaphire
A battery-powered, portable pair of plasma spheres (2,500 EUR) explicitly marketed by its own maker as 'experimental' and unable to make medical claims — designed for use away from mains power, including outdoors.
Piezo Phire
The most affordable device in the Implosion Group line (700 EUR) — a piezo-based localized 'implosive charge' unit launched at the maker's own FractalU conference.